Literature DB >> 3484495

Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers.

C L Yu, D Haskard, D Cavender, M Ziff.   

Abstract

Preincubation of human umbilical vein endothelial cell (EC) monolayers with 1 ng to 10 micrograms/ml lipopolysaccharide (LPS) increased the binding of T lymphocytes to EC. The effect was maximal at LPS concentrations of 0.1 to 10 micrograms/ml, and occurred with LPS derived from Escherichia coli (serotypes 0111:B4 and 0127:B8), Shigella flexneri (serotype 2a), Serratia marcescens (serotype 0:3), and Yersinia entercolitica (serotype 0:3). The increased binding appeared to be mediated primarily through an action on EC; preincubation of T cells rather than EC with LPS did not lead to enhanced binding. The onset of enhanced binding was very rapid, being observed after 2 to 3 min of preincubation and becoming maximal after 1 hr. EC were unresponsive to LPS after fixation with 2% paraformaldehyde-L-lysine-periodate and also when the LPS was incubated with EC at 4 degrees C. Enhanced binding was seen with lipid A and with LPS from Salmonella minnesota Re 595 (mainly lipid A) and was abolished by conjugation with polymyxin B. The observed increase in the binding of lymphocytes to EC exposed to LPS suggests that the lymphocytopenia induced by endotoxemia may result from augmentation of the adherence of lymphocytes to altered endothelium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis.

Authors:  O FitzGerald; M Soden; G Yanni; R Robinson; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells.

Authors:  M H Thornhill; U Kyan-Aung; T H Lee; D O Haskard
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

4.  Bruceine B, a potent inhibitor of leukocyte-endothelial cell adhesion.

Authors:  N Utoguchi; T Nakata; H H Cheng; K Ikeda; H Makimoto; Y Mu; S Nakagawa; M Kobayashi; I Kitagawa; T Mayumi
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

5.  T-cell adhesion to endothelial cells in systemic lupus erythematosis.

Authors:  D O Haskard; D Cavender; D Maliakkal; M Ziff
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

6.  Binding of macrophages and B lymphocytes mediated by dengue virus antigen and the virus-induced helper cytokine.

Authors:  N Rizvi; P Chaturvedi; U C Chaturvedi
Journal:  Int J Exp Pathol       Date:  1993-04       Impact factor: 1.925

7.  Porins and lipopolysaccharide (LPS) from Salmonella typhimurium induce leucocyte transmigration through human endothelial cells in vitro.

Authors:  M Galdiero; A Folgore; M Molitierno; R Greco
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

8.  Lipopolysaccharide augments HLA-A,B,C molecule expression but inhibits interferon-gamma-induced HLA-DR molecule expression on cultured human endothelial cells.

Authors:  A Otsuka; T Hanafusa; N Kono; S Tarui
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

9.  Adherence of human basophils to cultured umbilical vein endothelial cells.

Authors:  B S Bochner; P T Peachell; K E Brown; R P Schleimer
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

10.  Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus.

Authors:  V G Sasseville; W A Newman; A A Lackner; M O Smith; N C Lausen; D Beall; D J Ringler
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.